Catalysts for $ALVO
18 tracked
Dec 1, 2025
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Nov 19, 2025
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Nov 6, 2025
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Oct 16, 2025
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Apr 30, 2025
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Apr 7, 2025
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Apr 7, 2025
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Feb 14, 2025
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Feb 12, 2025
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Oct 18, 2024
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Oct 18, 2024
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Oct 18, 2024
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Aug 26, 2024
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Aug 26, 2024
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Jun 26, 2024
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
May 31, 2024
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→
Apr 16, 2024
approval
SELARSDI (USTEKINUMAB-AEKN) — FDA approval
Alvotech
→
Feb 23, 2024
approval
SIMLANDI (ADALIMUMAB-RYVK) — FDA approval
Alvotech
→